Most of the adverse outcomes we’ve attributed to the new SARS-CoV-2 variants, we trace back to point mutations located in the receptor binding domain. But they also have mutations in the N-terminal domain that we’d be remiss to neglect.
This Region Of The Covid-19 Virus Is One We Can’t Ignore
